[1] Reed GW, Rossi JE, Cannon CP.Acute myocardial infarction[J]. Lancet, 2017,389(10065): 197-210.
[2] Lee RC, Ambros V.An Extensive Class of Small RNAs in Caenorhabditis elegans[J]. Science, 2001, 294(5543): 862-864.
[3] Boon RA, Dimmeler S.MicroRNAs in myocardial infarction[J]. Nature Reviews Cardiology, 2014, 12(3): 135-142.
[4] Olivetti G, Quaini F, Sala R, et al.Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart[J]. J Mol Cell Cardiol, 1996, 28(9): 2005-2016.
[5] Wu L, Chen Y, Chen Y, et al.Effect of HIF‐1α/miR‐10b‐5p/PTEN on Hypoxia‐Induced Cardiomyocyte Apoptosis[J]. Journal of the American Heart Association, 2019, 8(18): e011948.
[6] Guo J, Liu H, Sun C, et al.MicroRNA-155 Promotes Myocardial Infarction-Induced Apoptosis by Targeting RNA-Binding Protein QKI[J]. Oxidative Medicine and Cellular Longevity, 2019, 2019: 1-14.
[7] Song Y, Zhang C, Zhang J, et al.Localized injection of miRNA-21-enriched extracellular vesicles effectively restores cardiac function after myocardial infarction[J]. Theranostics, 2019, 9(8): 2346-2360.
[8] Wang Y, Jiang Y, Sun X, et al.Downregulation of miR-200a protects cardiomyocyte against apoptosis[J]. Biomedicine Pharmacotherapy, 2020, 123: 109303.
[9] Yan K, An T, Zhai M, et al.Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2[J]. Cell Death & Disease, 2019, 10(7): 500.
[10] Thum T.Noncoding RNAs and myocardial fibrosis[J]. Nature Reviews Cardiology, 2014, 11(11): 655-663.
[11] Wang Y, Jin BJ, Chen Q, et al.MicroRNA-29b upregulation improves myocardial fibrosis and cardiac function in myocardial infarction rats through targeting SH2B3[J]. European Review for Medical & Pharmacological Sciences, 2019, 23(22): 10115-10122.
[12] Xiao Y, Zhang Y, Chen Y, et al.Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice[J]. Human Gene Therapy, 2019, 30(3): 286-301.
[13] Zhou Y, Richards AM, Wang P.MicroRNA-221 Is Cardioprotective and Anti-fibrotic in a Rat Model of Myocardial Infarction[J]. Molecular Therapy Nucleic Acids, 2019,17: 185-197.
[14] Li C, Li J, Xue K, et al.MicroRNA-143-3p promotes human cardiac fibrosis via targeting sprouty3 after myocardial infarction[J]. Journal of Molecular and Cellular Cardiology, 2019, 129: 281-292.
[15] Yuan X, Pan J, Wen L, et al.MiR‐590‐3p regulates proliferation, migration and collagen synthesis of cardiac fibroblast by targeting ZEB1[J]. Journal of Cellular and Molecular Medicine, 2019, 24(1): 227-237.
[16] Huang W, Feng Y, Liang J, et al.Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration[J]. Nature Communications, 2018, 9(1): 700.
[17] Wu X, Reboll MR, Korf-Klingebiel M, et al.Angiogenesis after acute myocardial infarction[J]. Cardiovascular Research, 2021, 117(5): 1257-1273.
[18] Li C, Qiu X, Sun Q, et al.Endogenous reduction of miR-185 accelerates cardiac function recovery in mice following myocardial infarction via targeting of cathepsin K[J]. Journal of Cellular and Molecular Medicine, 2019, 23(2): 1164-1173.
[19] Qiao L, Hu S, Liu S, et al.microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential[J]. The Journal of Clinical Investigation, 2019, 129(6): 2237-2250.
[20] Youn S, Li Y, Kim Young-Mee, et al.Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis[J]. Antioxidants, 2019, 8(1): 18.
[21] Arif M, Pandey R, Alam P, et al.MicroRNA-210-mediated proliferation, survival, and angiogenesis promote cardiac repair post myocardial infarction in rodents[J]. Journal of Molecular Medicine, 2017, 95(12): 1369-1385.
[22] Li X, Xue X, Sun Y, et al.MicroRNA-326-5p enhances therapeutic potential of endothelial progenitor cells for myocardial infarction[J]. Stem Cell Research & Therapy, 2019, 10(1): 323.
[23] Sanders LN, Schoenhard JA, Saleh MA, et al.BMP antagonist gremlin 2 limits inflammation after myocardial infarction[J]. Circulation Research, 2016, 119(3): 434-449.
[24] Zhou W, Ji L, Liu X, et al.AIFM1, negatively regulated by miR-145-5p, aggravates hypoxia-induced cardiomyocyte injury[J]. Biomedical Journal, 2022, 45(6): 870-882.
[25] Ge Z, Zhu X, Wang B, et al.MicroRNA-26b relieves inflammatory response and myocardial remodeling of mice with myocardial infarction by suppression of MAPK pathway through binding to PTGS2[J]. International Journal of Cardiology, 2019, 280: 152-159.
[26] Liu D, Qiao C, Luo H.MicroRNA-1278 ameliorates the inflammation of cardiomyocytes during myocardial ischemia by targeting both IL-22 and CXCL14[J]. Life Sciences, 2021, 269: 118817.
[27] Chu X, Wang Y, Pang L, et al.miR‐130 aggravates acute myocardial infarction‐induced myocardial injury by targeting PPAR‐γ[J]. Journal of Cellular Biochemistry, 2018, 119(9): 7235-7244.
[28] Yue R, Lu S, Luo Y, et al.Mesenchymal stem cell-derived exosomal microRNA-182-5p alleviates myocardial ischemia/reperfusion injury by targeting GSDMD in mice[J]. Cell Death Discovery, 2022, 8(1): 202.
[29] Ellis BW, Ronan G, Ren X, et al.Human Heart Anoxia and Reperfusion Tissue (HEART) Model for the Rapid Study of Exosome Bound miRNA Expression As Biomarkers for Myocardial Infarction[J]. Small, 2022, 18(28): e2201330.
[30] Marinescu MC, Lazar AL, Marta MM, et al.Non-Coding RNAs: Prevention, Diagnosis, and Treatment in Myocardial Ischemia-Reperfusion Injury[J]. Int J Mol Sci, 2022, 23(5): 2728.
[31] Davidson SM, Andreadou I, Barile L, et al.Circulating blood cells and extracellular vesicles in acute cardioprotection[J]. Cardiovasc Res, 2019, 115(7): 1156-1166.
[32] Shi HT, Huang ZH, Xu TZ, et al.New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials[J]. EBioMedicine, 2022, 78: 103968. |
